National Institute on Aging; Notice of Closed Meetings, 39000-39001 [2019-16923]
Download as PDF
<![CDATA[
39000
Federal Register / Vol. 84, No. 153 / Thursday, August 8, 2019 / Notices
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Independent AITC SEP.
Date: August 30, 2019.
Time: 10:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 5601
Fishers Lane, Rockville, MD 20892
(Telephone Conference Call).
Contact Person: James T. Snyder, Ph.D.
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities/
Room 3G31B, National Institutes of Health,
NIAID 5601 Fishers Lane, MSC 9823,
Rockville, MD 20892, (240) 669–5060,
james.snyder@nih.gov.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIAID Clinical Trial
Planning Grants (R34).
Date: September 3, 2019.
Time: 3:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 5601
Fishers Lane, Rockville, MD 20892
(Telephone Conference Call).
Contact Person: Priti Mehrotra, Ph.D.,
Chief, Immunology Review Branch, Scientific
Review Program, Division of Extramural
Activities, Room #3G40, National Institutes
of Health/NIAID, 5601 Fishers Lane, MSC
9823, Bethesda, MD 20892–7616, 240–669–
5066, pmehrotra@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: August 2, 2019.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–16926 Filed 8–7–19; 8:45 am]
BILLING CODE 4140–01–P
jbell on DSK3GLQ082PROD with NOTICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Environmental
Health Sciences Amended; Notice of
Meeting.
Notice is hereby given of a change in
the meeting of the National Advisory
VerDate Sep<11>2014
16:51 Aug 07, 2019
Jkt 247001
Environmental Health Sciences Council,
which was published in the Federal
Register on February 15, 2019, 84 FR,
4502.
This notice is being amended due to
change of meeting location. The meeting
will be held at Durham Convention
Center (Junior Ballroom AB), 301
Morgan Street, Durham, NC 27701. The
meeting is partially Closed to the public.
Dated: August 2, 2019.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–16956 Filed 8–7–19; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Special Emphasis Panel; Resource
Center for Minority Aging Research (RCMAR)
ZAG1 ZIJ–9 J1.
Date: October 31–November 1, 2019.
Time: October 31, 2019, 6:00 p.m. to 9:00
p.m.
Agenda: To evaluate and review grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Time: November 01, 2019, 8:00 a.m. to 5:00
p.m.
Agenda: To evaluate and review grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Time: 6:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Carmen Moten, Ph.D.,
MPH, Scientific Review Officer, Scientific
Review Branch, National Institute on Aging,
PO 00000
Frm 00074
Fmt 4703
Sfmt 4703
National Institutes of Health, Gateway Bldg.,
2C218, 7201 Wisconsin Avenue, Bethesda,
MD 20892, 301–402–7703, cmoten@
mail.nih.gov.
Name of Committee: National Institute on
Aging Special Emphasis Panel; Resource
Center for Minority Aging Research (RCMAR)
ZAG1 ZIJ–9 J3.
Date: October 31–November 1, 2019.
Time: October 31, 2019, 6:00 p.m. to 9:00
p.m.
Agenda: To evaluate and review grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Time: November 01, 2019, 8:00 a.m. to 5:00
p.m.
Agenda: To evaluate and review grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Time: 6:00 p.m. to 5:00 p.m.
Agenda: To evaluate and review grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Carmen Moten, Ph.D.,
MPH, Scientific Review Officer, Scientific
Review Branch, National Institute on Aging,
National Institutes of Health, Gateway Bldg.,
2C218, 7201 Wisconsin Avenue, Bethesda,
MD 20892, 301–402–7703, cmoten@
mail.nih.gov.
Name of Committee: National Institute on
Aging Special Emphasis Panel; Resource
Center for Minority Aging Research (RCMAR)
ZAG1 ZIJ–9 J3.
Date: October 31–November 1, 2019.
Time: October 31, 2019, 6:00 p.m. to 9:00
p.m.
Agenda: To evaluate and review grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Time: November 01, 2019, 8:00 a.m. to 5:00
p.m.
Agenda: To evaluate and review grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Time: 6:00 p.m. to 5:00 p.m.
Agenda: To evaluate and review grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Carmen Moten, Ph.D.,
MPH, Scientific Review Officer, Scientific
Review Branch, National Institute on Aging,
National Institutes of Health, Gateway Bldg.,
2C218, 7201 Wisconsin Avenue, Bethesda,
MD 20892, 301–402–7703, cmoten@
mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
E:\FR\FM\08AUN1.SGM
08AUN1
39001
Federal Register / Vol. 84, No. 153 / Thursday, August 8, 2019 / Notices
Dated: August 2, 2019.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–16923 Filed 8–7–19; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
jbell on DSK3GLQ082PROD with NOTICES
Name of Committee: National Institute on
Aging Special Emphasis Panel; T32 and T35
Review, January 2020 Council ZAG1 ZIJ–U
(J4).
Date: October 18, 2019.
Time: 8:00 a.m. to 6:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Anita H. Undale, MD,
Ph.D., Scientific Review Officer, Scientific
Review Branch, National Institute on Aging,
National Institutes of Health, Gateway
Building, Suite 2W200, 7201 Wisconsin
Avenue, Bethesda, MD 20892, 301–827–
7428, anita.undale@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
Dated: August 2, 2019.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–16955 Filed 8–7–19; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Prospective Grant of Exclusive Patent
License: Lutetium-177
Radiotherapeutics Against
Glioblastoma Multiforme and SmallCell Lung Carcinoma
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
NIH Ref No.
Patent No. or patent
application No.
Filing date
E–150–2016–0–US–01 .............
62/333,427 ..................
May 9, 2016 ...............
E–150–2016–0–PCT–02 ...........
PCT/US2017/031696
May 9, 2017 ...............
E–150–2016–0–CN–03 .............
201780029003X .........
November 9, 2018 ......
E–150–2016–0–EP–04 ..............
17796666.0 .................
November 12, 2018 ....
E–150–2016–0–JP–05 ..............
2018–558662 ..............
November 8, 2018 ......
E–150–2016–0–US–06 .............
16/099,488 ..................
November 7, 2018 ......
E–150–2016–0–SG–07 .............
11201809982R ...........
November 9, 2018 ......
E–150–2016–1–PCT–01 ...........
PCT/US2017/054863
October 3, 2017 .........
The patent rights in these inventions
have been assigned to the Government
of the United States of America. The
prospective patent license will be
granted worldwide and in a field of use
not broader than Lutetium-177
radiotherapeutics containing RGDpeptide moieties targeting integrin
avb3-expressing glioblastoma
multiforme and small cell lung cancers.
The invention pertains to a
radiotherapeutic against cancers that
overexpress integrin avb3. RGD peptide-
VerDate Sep<11>2014
16:51 Aug 07, 2019
Jkt 247001
Frm 00075
Fmt 4703
Only written comments and/or
applications for a license which are
received by the NHLBI Office of
Technology Transfer and Development
August 23, 2019 will be considered.
DATES:
Requests for copies of the
patent applications, inquiries, and
comments relating to the contemplated
exclusive patent license should be
directed to: Michael Shmilovich, Esq.,
Senior Licensing and Patent Manager,
31 Center Drive, Room 4A29, MSC2479,
Bethesda, MD 20892–2479, phone
number 301–435–5019, or shmilovm@
mail.nih.gov.
ADDRESSES:
The
following and all continuing U.S. and
foreign patents/patent applications
thereof are the intellectual properties to
be licensed under the prospective
agreement to MTTI:
SUPPLEMENTARY INFORMATION:
Title
Chemical Conjugates of Evans Blue Derivatives and
and Imaging Agents.
Chemical Conjugates of Evans Blue Derivatives and
and Imaging Agents.
Chemical Conjugates of Evans Blue Derivatives and
and Imaging Agents.
Chemical Conjugates of Evans Blue Derivatives and
and Imaging Agents.
Chemical Conjugates of Evans Blue Derivatives and
and Imaging Agents.
Chemical Conjugates of Evans Blue Derivatives and
and Imaging Agents.
Chemical Conjugates of Evans Blue Derivatives and
and Imaging Agents.
Chemical Conjugates of Evans Blue Derivatives And
And Imaging Agents.
targeted radionuclide therapy directed
against tumors that express integrin
avb3 has proven effective for the
treatment of advanced, low- to
intermediate-grade tumors. The subject
radiotherapeutic covered by the patent
estate includes an RGD peptide
(arginylglycylaspartic acid [Arg-GlyAsp], linear or cyclical), conjugated to
an Evans Blue (EB) analog, and further
chelated via DOTA to therapeutic
radionuclide 177Lu, a beta emitter. The
EB analog reversibly binds to circulating
PO 00000
The National Heart, Lung and
Blood Institute (NHLBI), National
Institutes of Health, Department of
Health and Human Services, is
contemplating the grant of an exclusive
patent license to Molecular Targeting
Technologies, Inc. (MTTI); a Delaware
corporation, with its principle place of
business in West Chester, Pennsylvania,
to practice the inventions embodied in
the patent application listed in the
Supplementary Information section of
this notice.
SUMMARY:
Sfmt 4703
Their Use as Radiotherapy
Their Use as Radiotherapy
Their Use as Radiotherapy
Their Use as Radiotherapy
Their Use as Radiotherapy
Their Use as Radiotherapy
Their Use as Radiotherapy
Their Use As Radiotherapy
serum albumin and improves the
pharmacokinetics of RGD peptide
DOTA conjugated radiotherapeutics and
potentially toxicity. The EB analog
conjugated has been shown by the
inventors to provide reversible albumin
binding in vivo and extended half-life in
circulation. This notice is made in
accordance with 35 U.S.C. 209 and 37
CFR part 404. The prospective exclusive
patent license will be royalty bearing
and may be granted unless within
fifteen (15) days from the date of this
E:\FR\FM\08AUN1.SGM
08AUN1
]]>Agencies
[Federal Register Volume 84, Number 153 (Thursday, August 8, 2019)]
[Notices]
[Pages 39000-39001]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-16923]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute on Aging Special Emphasis
Panel; Resource Center for Minority Aging Research (RCMAR) ZAG1 ZIJ-
9 J1.
Date: October 31-November 1, 2019.
Time: October 31, 2019, 6:00 p.m. to 9:00 p.m.
Agenda: To evaluate and review grant applications.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400
Wisconsin Avenue, Bethesda, MD 20814.
Time: November 01, 2019, 8:00 a.m. to 5:00 p.m.
Agenda: To evaluate and review grant applications.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400
Wisconsin Avenue, Bethesda, MD 20814.
Time: 6:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Carmen Moten, Ph.D., MPH, Scientific Review
Officer, Scientific Review Branch, National Institute on Aging,
National Institutes of Health, Gateway Bldg., 2C218, 7201 Wisconsin
Avenue, Bethesda, MD 20892, 301-402-7703, [email protected].
Name of Committee: National Institute on Aging Special Emphasis
Panel; Resource Center for Minority Aging Research (RCMAR) ZAG1 ZIJ-
9 J3.
Date: October 31-November 1, 2019.
Time: October 31, 2019, 6:00 p.m. to 9:00 p.m.
Agenda: To evaluate and review grant applications.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400
Wisconsin Avenue, Bethesda, MD 20814.
Time: November 01, 2019, 8:00 a.m. to 5:00 p.m.
Agenda: To evaluate and review grant applications.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400
Wisconsin Avenue, Bethesda, MD 20814.
Time: 6:00 p.m. to 5:00 p.m.
Agenda: To evaluate and review grant applications.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Carmen Moten, Ph.D., MPH, Scientific Review
Officer, Scientific Review Branch, National Institute on Aging,
National Institutes of Health, Gateway Bldg., 2C218, 7201 Wisconsin
Avenue, Bethesda, MD 20892, 301-402-7703, [email protected].
Name of Committee: National Institute on Aging Special Emphasis
Panel; Resource Center for Minority Aging Research (RCMAR) ZAG1 ZIJ-
9 J3.
Date: October 31-November 1, 2019.
Time: October 31, 2019, 6:00 p.m. to 9:00 p.m.
Agenda: To evaluate and review grant applications.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400
Wisconsin Avenue, Bethesda, MD 20814.
Time: November 01, 2019, 8:00 a.m. to 5:00 p.m.
Agenda: To evaluate and review grant applications.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400
Wisconsin Avenue, Bethesda, MD 20814.
Time: 6:00 p.m. to 5:00 p.m.
Agenda: To evaluate and review grant applications.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Carmen Moten, Ph.D., MPH, Scientific Review
Officer, Scientific Review Branch, National Institute on Aging,
National Institutes of Health, Gateway Bldg., 2C218, 7201 Wisconsin
Avenue, Bethesda, MD 20892, 301-402-7703, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.866, Aging
Research, National Institutes of Health, HHS)
[[Page 39001]]
Dated: August 2, 2019.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2019-16923 Filed 8-7-19; 8:45 am]
BILLING CODE 4140-01-P
